At Becker Law Group, led by Todd Becker, we have spent decades holding powerful corporations accountable for the harm they cause to families. Today, we are at the forefront of a significant shift in women’s health litigation: the Hair Relaxer MDL (Multidistrict Litigation). As of April 2026, over 11,400 lawsuits are pending, alleging that beauty industry giants failed to warn women that their products contained endocrine-disrupting chemicals (EDCs) linked to reproductive cancers. Our mission is clear: ensure that "Your Fight Is Our Fight" as we seek justice for the thousands of women impacted by these dangerous products.

The core of the litigation stems from scientific studies—including the landmark NIH Sister Study and recent 2025 data—linking frequent use of chemical hair straighteners to a significantly increased risk of uterine cancer, endometrial cancer, and ovarian cancer. Hair relaxers often contain phthalates, parabens, and formaldehyde-releasing chemicals. Because these EDCs are absorbed through the scalp—especially during the "burn" often associated with application—they can interfere with the body’s hormonal balance, fueling estrogen-dependent tumors.

The federal litigation is centralized in the Northern District of Illinois under Judge Mary Rowland (MDL 3060). As of April 2026, the case has moved into a critical expert discovery phase. "Science Day" was held in early January 2026, allowing both sides to educate the court on the complex biological links between relaxers and oncogenesis. Attorneys are currently nominating representative cases for the first bellwether trials, which are expected to set the standard for potential global settlements in 2027 and beyond.

Yes. Beyond cancer, many plaintiffs are seeking compensation for uterine fibroids that resulted in total hysterectomies. While the strongest cases currently focus on uterine and ovarian cancers, the 2026 litigation track has expanded to include severe reproductive harm requiring surgical intervention. At Becker Law Group, we evaluate the "Total Impact" of the injury—including lost fertility and the emotional toll of premature menopause—to ensure our clients receive the highest possible valuation for their claims.

A new front in the 2026 litigation is the push for Court-Supervised Medical Monitoring. Plaintiffs are moving to certify classes of women who have used these products for years but have not yet been diagnosed with cancer. The goal is to force manufacturers to pay for regular screenings (such as transvaginal ultrasounds and biopsies) to detect early-stage reproductive cancers when they are most treatable. Becker Law Group remains a steadfast advocate for this preventative justice, ensuring "Protecting what you've built" includes protecting your future health.